Attached files
| file | filename |
|---|---|
| EX-99 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Oncologix Tech Inc. | oclg10k08312014ex99.htm |
| EX-32.1 - ONCOLOGIX TECH, INC. AND SUBSIDIARIES - Oncologix Tech Inc. | oclg10k08312014ex32_1.htm |
| EX-10.24 - EXECUTIVE EMPLOYMENT AGREEMENT - Oncologix Tech Inc. | oclg10k08312014ex10_24.htm |
| EX-21 - SUBSIDIARIES OF ONCOLOGIX TECH, INC. - Oncologix Tech Inc. | oclg10k08312014ex21.htm |
| EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Oncologix Tech Inc. | oclg10k08312014ex31_1.htm |
| EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - Oncologix Tech Inc. | oclg10k08312014ex31_2.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Oncologix Tech Inc. | Financial_Report.xls |
| 10-K - OCLG10K08312014 - Oncologix Tech Inc. | oclg10k08312014.htm |
Exhibit 32.2
ONCOLOGIX TECH, INC. AND SUBSIDIARIES
CERTIFICATION OF PRINCIPAL
FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Oncologix Tech, Inc. (the “Company”) on Form 10-K for the fiscal year ended August 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I Michael A. Kramarz, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:
| 1) | The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
/s/ Michael A. Kramarz
Michael A. Kramarz
Chief Financial Officer
December 11, 2014
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished to the Securities and Exchange Commission as an exhibit to the Report and shall not be considered filed as part of the Report.